A detailed history of Cibc Private Wealth Group, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,386 shares of NTRA stock, worth $280,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,386
Previous 3,371 29.22%
Holding current value
$280,355
Previous $308,000 16.23%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$85.28 - $112.6 $84,000 - $110,911
-985 Reduced 29.22%
2,386 $258,000
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $126,581 - $211,159
3,371 New
3,371 $211,000
Q1 2023

Nov 21, 2023

BUY
$36.57 - $58.29 $133,114 - $212,175
3,640 New
3,640 $202,000
Q1 2023

May 11, 2023

BUY
$36.57 - $58.29 $133,114 - $212,175
3,640 New
3,640 $202,000
Q1 2021

May 12, 2021

SELL
$91.47 - $124.36 $260,689 - $354,426
-2,850 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $189,981 - $318,459
2,850 New
2,850 $284,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $11.4B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.